Respiratory Micronization for Optimal Drug Delivery
Munit is a world-class provider of specialized micronization services for respiratory products, including inhalation powders for metered-dose inhalers (MDI) and dry powder inhalers (DPI). Our advanced technology and state-of-the-art facilities enable us to micronize Active Pharmaceutical Ingredients (APIs) and High Potency APIs (HPAPIs) with precision and consistency to ensure optimal performance and efficacy.
Our team of experts is highly experienced in developing and optimizing micronization processes for respiratory products. We are specialized in providing the desired Particle Size Distribution (PSD) in the range of 1-5 microns, which is critical for achieving optimal lung deposition and targeting.
Micronization of lung-targeted APIs and HPAPIs is essential for effective drug delivery. By reducing particle size in the range of 1-5 microns, the drug particles can reach the target area more efficiently, increasing the drug's bioavailability and therapeutic efficacy. This approach is essential for patients with respiratory diseases like asthma, Chronic Obstructive Pulmonary Disease (COPD), and cystic fibrosis.
We follow strict protocols and use advanced analytical capabilities for consistent and precise particle size distributions to ensure our respiratory products meet high safety and efficacy standards. Optimal drug delivery and therapeutic efficacy are thus achieved.
Contact us to learn more about our services and how we can help your business succeed.